GlaxoSmithKline Pharmaceuticals Limited — Dividend/Bonus, 29-10-2024: Record Date

GlaxoSmithKline Pharmaceuticals reported its unaudited financial results for Q2 and the first half of FY2024, showing revenue from operations of ₹100,005 lakhs and a net profit of ₹24,869 lakhs. The Board declared a special interim dividend of ₹12 per equity share, reflecting a 120% payout. The company reported a cash decrease of ₹2,366 lakhs during the period, with total assets at ₹373,009 lakhs. The results include exceptional items related to the sale of surplus properties.